Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Baumstein
S Block
J Whitworth

Showing results (561-570 of 601) with videos related to

Pageof 61
Sort By:
American Journal of Ophthalmology|November 20, 2012
Surveillance of disparities in vision and eye health in the United States: an expert panel's opinionsPaul P Lee, Sheila K West, Sandra S Block, et al.
Journal of Immunotherapy and Precision Oncology|February 8, 2024
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from MelanomaUgur Sener, Mason Webb, William G Breen, et al.
Cancer Research|November 16, 2014
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancerEvanthia Galanis, Pamela J Atherton, Matthew J Maurer, et al.
Science Translational Medicine|March 1, 2023
A cell-penetrant peptide blocking <i>C9ORF72</i>-repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteinsLydia M Castelli, Ya-Hui Lin, Alvaro Sanchez-Martinez, et al.
Cancer Research|April 15, 2014
Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancerChen Wang, Mine S Cicek, Bridget Charbonneau, et al.
Plos One|March 21, 2020
Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutationsThomas T DeLeon, Daniel R Almquist, Benjamin R Kipp, et al.
Journal for Immunotherapy of Cancer|June 7, 2020
Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trialDmitriy Zamarin, Sven Walderich, Aliya Holland, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|June 19, 2023
Prescribing patterns for paediatric hyperopia among paediatric eye care providersAnn M Morrison, Marjean T Kulp, Elise B Ciner, et al.
Oncoimmunology|December 14, 2020
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1Neeta Somaiah, Sant P Chawla, Matthew S Block, et al.
Nature Communications|October 27, 2023
N-terminal acetylation shields proteins from degradation and promotes age-dependent motility and longevitySylvia Varland, Rui Duarte Silva, Ine Kjosås, et al.
Pageof 61

Showing results (561-570 of 601) with videos related to

Sort By:
Pageof 61
American Journal of Ophthalmology|November 20, 2012
Surveillance of disparities in vision and eye health in the United States: an expert panel's opinionsPaul P Lee, Sheila K West, Sandra S Block, et al.
Journal of Immunotherapy and Precision Oncology|February 8, 2024
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from MelanomaUgur Sener, Mason Webb, William G Breen, et al.
Cancer Research|November 16, 2014
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancerEvanthia Galanis, Pamela J Atherton, Matthew J Maurer, et al.
Science Translational Medicine|March 1, 2023
A cell-penetrant peptide blocking <i>C9ORF72</i>-repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteinsLydia M Castelli, Ya-Hui Lin, Alvaro Sanchez-Martinez, et al.
Cancer Research|April 15, 2014
Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancerChen Wang, Mine S Cicek, Bridget Charbonneau, et al.
Plos One|March 21, 2020
Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutationsThomas T DeLeon, Daniel R Almquist, Benjamin R Kipp, et al.
Journal for Immunotherapy of Cancer|June 7, 2020
Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trialDmitriy Zamarin, Sven Walderich, Aliya Holland, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|June 19, 2023
Prescribing patterns for paediatric hyperopia among paediatric eye care providersAnn M Morrison, Marjean T Kulp, Elise B Ciner, et al.
Oncoimmunology|December 14, 2020
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1Neeta Somaiah, Sant P Chawla, Matthew S Block, et al.
Nature Communications|October 27, 2023
N-terminal acetylation shields proteins from degradation and promotes age-dependent motility and longevitySylvia Varland, Rui Duarte Silva, Ine Kjosås, et al.
Pageof 61